Laboratorio Reig (Spain) Performance
| RJF Stock | EUR 2.78 0.01 0.36% |
Laboratorio Reig has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.18, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Laboratorio Reig's returns are expected to increase less than the market. However, during the bear market, the loss of holding Laboratorio Reig is expected to be smaller as well. Laboratorio Reig Jofre right now secures a risk of 1.68%. Please verify Laboratorio Reig Jofre total risk alpha, value at risk, and the relationship between the standard deviation and treynor ratio , to decide if Laboratorio Reig Jofre will be following its current price movements.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Laboratorio Reig Jofre are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Laboratorio Reig is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 11.6 M | |
| Total Cashflows From Investing Activities | -34.7 M |
Laboratorio |
Laboratorio Reig Relative Risk vs. Return Landscape
If you would invest 271.00 in Laboratorio Reig Jofre on August 31, 2024 and sell it today you would earn a total of 7.00 from holding Laboratorio Reig Jofre or generate 2.58% return on investment over 90 days. Laboratorio Reig Jofre is generating 0.0536% of daily returns assuming 1.6776% volatility of returns over the 90 days investment horizon. Simply put, 14% of all stocks have less volatile historical return distribution than Laboratorio Reig, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Laboratorio Reig Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Laboratorio Reig's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Laboratorio Reig Jofre, and traders can use it to determine the average amount a Laboratorio Reig's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.032
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | RJF | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.68 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Laboratorio Reig is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Laboratorio Reig by adding it to a well-diversified portfolio.
Laboratorio Reig Fundamentals Growth
Laboratorio Stock prices reflect investors' perceptions of the future prospects and financial health of Laboratorio Reig, and Laboratorio Reig fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Laboratorio Stock performance.
| Return On Equity | 0.0223 | |||
| Return On Asset | 0.0165 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 245.01 M | |||
| Shares Outstanding | 76.7 M | |||
| Price To Earning | 16.69 X | |||
| Price To Book | 0.99 X | |||
| Price To Sales | 0.71 X | |||
| Revenue | 236.23 M | |||
| EBITDA | 24.53 M | |||
| Cash And Equivalents | 33.99 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 34.67 M | |||
| Debt To Equity | 22.70 % | |||
| Book Value Per Share | 2.49 X | |||
| Cash Flow From Operations | 14.5 M | |||
| Earnings Per Share | 0.06 X | |||
| Total Asset | 324.98 M | |||
About Laboratorio Reig Performance
By analyzing Laboratorio Reig's fundamental ratios, stakeholders can gain valuable insights into Laboratorio Reig's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Laboratorio Reig has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Laboratorio Reig has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and nutritional supplements. Laboratorio Reig Jofre, S.A. was founded in 1929 and is based in Barcelona, Spain. LABORATORIO REIG operates under Drug Manufacturers - Specialty Generic classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1000 people.Things to note about Laboratorio Reig Jofre performance evaluation
Checking the ongoing alerts about Laboratorio Reig for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Laboratorio Reig Jofre help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 78.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Laboratorio Reig's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Laboratorio Reig's stock is overvalued or undervalued compared to its peers.
- Examining Laboratorio Reig's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Laboratorio Reig's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Laboratorio Reig's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Laboratorio Reig's stock. These opinions can provide insight into Laboratorio Reig's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Laboratorio Stock analysis
When running Laboratorio Reig's price analysis, check to measure Laboratorio Reig's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorio Reig is operating at the current time. Most of Laboratorio Reig's value examination focuses on studying past and present price action to predict the probability of Laboratorio Reig's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorio Reig's price. Additionally, you may evaluate how the addition of Laboratorio Reig to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |